{"entity":{"type":"insider","cik":"0001716213","url":"/insider/0001716213","json_url":"/insider/0001716213.json","name":"Hamill John P.","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":10,"first":"2019-06-04","last":"2026-02-02","span_basis":"filed_date"},"name_variants":[{"name":"Hamill John P.","source":"filing","n_filings":10,"first_seen":"2019-06-04","last_seen":"2026-02-02"}],"transactions":[{"id":6165295,"accession":"0001104659-26-009203","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-26-009203","line_url":"/filing/0001104659-26-009203#line-1","is_derivative":false,"issuer_cik":"0001716213","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001716213","owner_cik":"0001716213","owner_name":"Hamill John P.","owner_display_name":"Hamill John P.","owner_url":"/insider/0001716213","role":"Officer (SrVP/CFO/Prin Fin & Acct Ofcr)","role_mark":"O","role_mark_label":"Officer (SrVP/CFO/Prin Fin & Acct Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SrVP/CFO/Prin Fin & Acct Ofcr","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5700.0,"shares_display":"5,700","price_per_share":0.89,"price_display":"0.89","price_state":"stated","total_value":5073.0,"total_display":"5,073.00","total_whole":"5,073","shares_owned_after":33433.0,"shares_owned_after_display":"33,433","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-30","filed_date":"2026-02-02","scope":"insider"},{"id":4549920,"accession":"0001104659-25-120155","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-25-120155","line_url":"/filing/0001104659-25-120155#line-1","is_derivative":false,"issuer_cik":"0001716213","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001716213","owner_cik":"0001716213","owner_name":"Hamill John P.","owner_display_name":"Hamill John P.","owner_url":"/insider/0001716213","role":"Officer (SrVP/CFO/Prin Fin & Acct Ofcr)","role_mark":"O","role_mark_label":"Officer (SrVP/CFO/Prin Fin & Acct Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SrVP/CFO/Prin Fin & Acct Ofcr","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":1.165,"price_display":"1.16","price_state":"stated","total_value":5825.0,"total_display":"5,825.00","total_whole":"5,825","shares_owned_after":27733.0,"shares_owned_after_display":"27,733","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-12-10","filed_date":"2025-12-11","scope":"insider"},{"id":2051826,"accession":"0001104659-24-108962","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-108962","line_url":"/filing/0001104659-24-108962#line-1","is_derivative":false,"issuer_cik":"0001716213","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001716213","owner_cik":"0001716213","owner_name":"Hamill John P.","owner_display_name":"Hamill John P.","owner_url":"/insider/0001716213","role":"Officer (SrVP/CFO/Prin Fin & Acct Ofcr)","role_mark":"O","role_mark_label":"Officer (SrVP/CFO/Prin Fin & Acct Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SrVP/CFO/Prin Fin & Acct Ofcr","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":50.0,"shares_display":"50","price_per_share":2.4638,"price_display":"2.46","price_state":"stated","total_value":123.19,"total_display":"123.19","total_whole":"123","shares_owned_after":19368.0,"shares_owned_after_display":"19,368","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-11","filed_date":"2024-10-16","scope":"insider"},{"id":3118389,"accession":"0001104659-24-108373","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-108373","line_url":"/filing/0001104659-24-108373#line-1","is_derivative":false,"issuer_cik":"0001716213","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001716213","owner_cik":"0001716213","owner_name":"Hamill John P.","owner_display_name":"Hamill John P.","owner_url":"/insider/0001716213","role":"Officer (SrVP/CFO/Prin Fin & Acct Ofcr)","role_mark":"O","role_mark_label":"Officer (SrVP/CFO/Prin Fin & Acct Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SrVP/CFO/Prin Fin & Acct Ofcr","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":450.0,"shares_display":"450","price_per_share":2.61,"price_display":"2.61","price_state":"stated","total_value":1174.5,"total_display":"1,174.50","total_whole":"1,175","shares_owned_after":19318.0,"shares_owned_after_display":"19,318","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-10-10","filed_date":"2024-10-15","scope":"insider"},{"id":3232164,"accession":"0001104659-24-034673","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001104659-24-034673","line_url":"/filing/0001104659-24-034673#line-1","is_derivative":false,"issuer_cik":"0001716213","issuer_name":"Aprea Therapeutics, Inc.","issuer_ticker":"APRE","issuer_name_source":null,"issuer_url":"/issuer/0001716213","owner_cik":"0001716213","owner_name":"Hamill John P.","owner_display_name":"Hamill John P.","owner_url":"/insider/0001716213","role":"Officer (SrVP/CFO/Prin Fin & Acct Ofcr)","role_mark":"O","role_mark_label":"Officer (SrVP/CFO/Prin Fin & Acct Ofcr)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SrVP/CFO/Prin Fin & Acct Ofcr","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1010.0,"shares_display":"1,010","price_per_share":7.29,"price_display":"7.29","price_state":"stated","total_value":7362.9,"total_display":"7,362.90","total_whole":"7,363","shares_owned_after":15503.0,"shares_owned_after_display":"15,503","ownership_form":"D","is_10b5_1":null,"transaction_date":"2024-03-13","filed_date":"2024-03-14","scope":"insider"},{"id":6570355,"accession":"0001437749-22-017793","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-22-017793","line_url":"/filing/0001437749-22-017793#line-1","is_derivative":false,"issuer_cik":"0000946486","issuer_name":"WINDTREE THERAPEUTICS INC /DE/","issuer_ticker":"WINT","issuer_name_source":null,"issuer_url":"/issuer/0000946486","owner_cik":"0001716213","owner_name":"Hamill John P.","owner_display_name":"Hamill John P.","owner_url":"/insider/0001716213","role":"Officer (SVP & CFO)","role_mark":"O","role_mark_label":"Officer (SVP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":3000.0,"shares_display":"3,000","price_per_share":0.3666,"price_display":"0.37","price_state":"stated","total_value":1099.8,"total_display":"1,099.80","total_whole":"1,100","shares_owned_after":72800.0,"shares_owned_after_display":"72,800","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-26","filed_date":"2022-07-26","scope":"insider"},{"id":5546117,"accession":"0001437749-21-009187","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-009187","line_url":"/filing/0001437749-21-009187#line-1","is_derivative":false,"issuer_cik":"0000946486","issuer_name":"WINDTREE THERAPEUTICS INC /DE/","issuer_ticker":"WINT","issuer_name_source":null,"issuer_url":"/issuer/0000946486","owner_cik":"0001716213","owner_name":"Hamill John P.","owner_display_name":"Hamill John P.","owner_url":"/insider/0001716213","role":"Officer (SVP & CFO)","role_mark":"O","role_mark_label":"Officer (SVP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.0669,"price_display":"2.07","price_state":"stated","total_value":2066.9,"total_display":"2,066.90","total_whole":"2,067","shares_owned_after":3500.0,"shares_owned_after_display":"3,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-04-16","filed_date":"2021-04-19","scope":"insider"},{"id":5514443,"accession":"0001437749-21-007172","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-21-007172","line_url":"/filing/0001437749-21-007172#line-1","is_derivative":false,"issuer_cik":"0000946486","issuer_name":"WINDTREE THERAPEUTICS INC /DE/","issuer_ticker":"WINT","issuer_name_source":null,"issuer_url":"/issuer/0000946486","owner_cik":"0001716213","owner_name":"Hamill John P.","owner_display_name":"Hamill John P.","owner_url":"/insider/0001716213","role":"Officer (SVP & CFO)","role_mark":"O","role_mark_label":"Officer (SVP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1500.0,"shares_display":"1,500","price_per_share":3.25,"price_display":"3.25","price_state":"stated","total_value":4875.0,"total_display":"4,875.00","total_whole":"4,875","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-03-25","filed_date":"2021-03-25","scope":"insider"},{"id":3184576,"accession":"0001437749-20-020957","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001437749-20-020957","line_url":"/filing/0001437749-20-020957#line-1","is_derivative":false,"issuer_cik":"0000946486","issuer_name":"WINDTREE THERAPEUTICS INC /DE/","issuer_ticker":"WINT","issuer_name_source":null,"issuer_url":"/issuer/0000946486","owner_cik":"0001716213","owner_name":"Hamill John P.","owner_display_name":"Hamill John P.","owner_url":"/insider/0001716213","role":"Officer (SVP & CFO)","role_mark":"O","role_mark_label":"Officer (SVP & CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"SVP & CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":5.27,"price_display":"5.27","price_state":"stated","total_value":5270.0,"total_display":"5,270.00","total_whole":"5,270","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2020-10-07","filed_date":"2020-10-09","scope":"insider"},{"id":7871513,"accession":"0001209191-19-034359","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-19-034359","line_url":"/filing/0001209191-19-034359#line-1","is_derivative":false,"issuer_cik":"0001429560","issuer_name":"TREVENA INC","issuer_ticker":"TRVN","issuer_name_source":null,"issuer_url":"/issuer/0001429560","owner_cik":"0001716213","owner_name":"Hamill John P.","owner_display_name":"Hamill John P.","owner_url":"/insider/0001716213","role":"Officer (VP Fin,Princ Fin&Acct Officer)","role_mark":"O","role_mark_label":"Officer (VP Fin,Princ Fin&Acct Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"VP Fin,Princ Fin&Acct Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":7500.0,"shares_display":"7,500","price_per_share":1.16,"price_display":"1.16","price_state":"stated","total_value":8700.0,"total_display":"8,700.00","total_whole":"8,700","shares_owned_after":87750.0,"shares_owned_after_display":"87,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-05-31","filed_date":"2019-06-04","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":10,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001781983","name":"Aprea Therapeutics, Inc.","url":"/issuer/0001781983","role":"Officer (SrVP/CFO/Prin Fin & Acct Ofcr)","n_filings":5,"first_seen":"2024-03-14","last_seen":"2026-02-02"},{"type":"issuer","type_label":"ISSUER","cik":"0000946486","name":"WINDTREE THERAPEUTICS INC /DE/","url":"/issuer/0000946486","role":"Officer (SVP & CFO)","n_filings":4,"first_seen":"2020-10-09","last_seen":"2022-07-26"},{"type":"issuer","type_label":"ISSUER","cik":"0001429560","name":"TREVENA INC","url":"/issuer/0001429560","role":"Officer (VP Fin,Princ Fin&Acct Officer)","n_filings":1,"first_seen":"2019-06-04","last_seen":"2019-06-04"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001716213","retrieved_at":"2026-08-22T22:14:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}